SCHEMBL2584239

SCHEMBL2584239

CCCCCCCCCCCCCCCCNCCC

nearest known ligand 0.81

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.81
ALDH1A1 P00352 1/20 0.81
EPHX1 P07099 4/20 0.55
ADH1B P00325 1/20 0.55
ADH1C P00326 1/20 0.55
ADH1A P07327 1/20 0.55
ADH4 P08319 1/20 0.55
ADH7 P40394 1/20 0.55
S1PR2 O95136 5/20 0.54
S1PR4 O95977 5/20 0.54
S1PR1 P21453 5/20 0.54
S1PR3 Q99500 5/20 0.54
S1PR5 Q9H228 1/20 0.54
PAOX Q6QHF9 1/20 0.52
CYP1A2 P05177 1/20 0.50
CYP2C19 P33261 1/20 0.50
THRB P10828 1/20 0.50
PPARA Q07869 2/20 0.48
SIGMAR1 Q99720 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1575855 1.00 TSHR (0.81) TSHRALDH1A1EPHX1ADH1BADH1C
SCHEMBL386694 1.00 TSHR (0.81) TSHRALDH1A1EPHX1ADH1BADH1C
SCHEMBL1396468 1.00 TSHR (0.81) TSHRALDH1A1EPHX1ADH1BADH1C
SCHEMBL4958373 1.00 TSHR (0.81) TSHRALDH1A1EPHX1ADH1BADH1C
SCHEMBL2845493 1.00 TSHR (0.81) TSHRALDH1A1EPHX1ADH1BADH1C
SCHEMBL1204398 1.00 TSHR (0.81) TSHRALDH1A1EPHX1ADH1BADH1C
SCHEMBL9801424 1.00 TSHR (0.81) TSHRALDH1A1EPHX1ADH1BADH1C
SCHEMBL117275 1.00 TSHR (0.81) TSHRALDH1A1EPHX1ADH1BADH1C
SCHEMBL21611681 1.00 TSHR (0.81) TSHRALDH1A1EPHX1ADH1BADH1C
SCHEMBL5467592 1.00 TSHR (0.81) TSHRALDH1A1EPHX1ADH1BADH1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11404657-B2 Method of fabricating perovskite periodic nanostructure including solid-liquid-solid phase transformation THE UNIVERSITY OF HONG KONG (CN) 2022-08-02 US claimed
CN-110003541-B Application of low-ammonia or ammonia-free latex in natural latex foaming product 中国热带农业科学院橡胶研究所 2022-01-14 CN claimed
US-20210376276-A1 Fabrication of Perovskite Periodic Arrays for Optoelectronic Applications THE UNIVERSITY OF HONG KONG (CN) 2021-12-02 US claimed
CN-109906288-B Preparation of periodic arrays of perovskites for photovoltaic applications 香港大学 2021-03-09 CN claimed
CN-110982131-A Method for producing latex foamed product by using low-protein latex 中国热带农业科学院橡胶研究所 2020-04-10 CN claimed
CN-110003541-A A kind of low ammonia or the application without ammoniacal latex in foamed latex product 中国热带农业科学院橡胶研究所 2019-07-12 CN claimed
CN-105814017-B The oxidation of 2 mercapto ethanol 巴斯夫欧洲公司 2019-02-12 CN claimed
EP-3080079-B1 OXIDATION OF 2-MERCAPTOETHANOL BASF SE (DE) 2018-07-25 EP claimed
US-20160318860-A1 OXIDATION OF 2-MERCAPTOETHANOL BASF SE (DE) 2016-11-03 US claimed
EP-3080079-A1 OXIDATION OF 2-MERCAPTOETHANOL BASF SE (DE) 2016-10-19 EP claimed
WO-2015086565-A1 OXIDATION OF 2-MERCAPTOETHANOL BASF SE (DE) 2015-06-18 WO claimed
US-6552108-B1 Thermal stability EXXONMOBIL CHEMICAL PATENTS INC. 2003-04-22 US claimed
US-4795781-A MOLDING MATERIALS MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) 1989-01-03 US claimed
EP-4700089-A1 POLYAMIDE RESIN COMPOSITION UBE Corporation (JP) 2026-02-25 EP disclosed
EP-3868740-B1 CARBOXYLIC ACID-TYPE LIPID, AND LIPID PARTICLE AND LIPID MEMBRANE CONTAINING CARBOXYLIC ACID-TYPE LIPID TORAY INDUSTRIES (JP) 2025-08-06 EP disclosed
US-20250205384-A1 HEMOSTATIC MATERIAL TORAY INDUSTRIES, INC. (JP) 2025-06-26 US disclosed
EP-0143464-A2 Pentaerythritol-spiro-bis-phosphite compositions having improved hydrolytic stability Argus Chemical Corporation (US) 1985-06-05 EP disclosed
US-4203923-A AMMONIA, AMMONIUM HYDROXIDE OR SECONDARY AMINE ALLIED CHEMICAL CORPORATION (US) 1980-05-20 US disclosed
US-4111920-A POLYETHER URETHANES AS ANTISTATIC ADDITIVES IN POLYAMIDE COMPOSITIONS BAYER AKTIENGESELLSCHAFT (DE) 1978-09-05 US disclosed
US-4003718-A Substituted tetrahydropyrimidines UNIVERSAL OIL PRODUCTS COMPANY (US) 1977-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250205384-A1 HEMOSTATIC MATERIAL F2, F12, FGB TSHR 1262/4885ALDH1A1 3966/4885EPHX1 480/4885
US-20160318860-A1 OXIDATION OF 2-MERCAPTOETHANOL HAO2, GPX4, SQOR TSHR 2733/4885ALDH1A1 1198/4885EPHX1 496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.